Cipla, Sony Hack, Nestle, Fogerty: Intellectual Property

Updated on

Cipla Ltd.’s request that India cancel patents covering five Novartis AG drugs isn’t finding much traction, the Times of India reported.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.